ID
27405
Description
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977
Keywords
Versions (3)
- 11/13/17 11/13/17 -
- 11/26/17 11/26/17 -
- 9/20/21 9/20/21 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 13, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Local Pathology Results GSK study Prostatic neoplasms NCT00883909
Local Pathology Results GSK study Prostatic neoplasms NCT00883909
Description
Local Pathology Results
Description
Date of Needle Biopsy or Surgery
Data type
date
Description
Type of Procedure
Data type
text
Description
Needle Biopsy indication
Data type
text
Description
other indication needle biopsy
Data type
text
Description
Prostate Cancer
Data type
text
Description
Gleason Grade
Data type
integer
Description
HGPIN
Data type
text
Description
ASAP
Data type
text
Description
Slides sent to Central Pathology
Data type
text
Description
Tissue sent to Central Pathology
Data type
text